proxyresults061010.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reportedly): June 10, 2010
OCEAN BIO-CHEM, INC.
(Exact name of registrant as specified in charter)
|
Florida
|
0-11102
|
59-1564329
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
(Address of principal executive office Zip Code)
(954) 587-6280
Registrant’s telephone number, including area code:
Not Applicable
(Former name or former address, if changes since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
Below is the results of voting from the shareholders annual meeting held on June 4, 2010, for the proposals in the 2010 Proxy Statement.
| |
|
|
|
|
|
| |
|
|
|
|
Abstain
|
| |
For
|
|
Against
|
|
or Withheld
|
|
Proposal 1
|
|
|
|
|
|
|
To elect nine directors to serve until the 2011 Annual Meeting of Shareholders or until their successors shall be elected and qualified;
|
5,845,342
|
|
-----
|
|
67,531
|
| |
|
|
|
|
|
|
Proposal 2.
|
|
|
|
|
|
|
To approve and ratify the issuance of restricted common stock issued to employees as compensation
|
5,784,621
|
|
108,591
|
|
17,578
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
Proposal 3.
|
|
|
|
|
|
|
To approve and ratify the issuance of Non-Qualified Director’s Stock Options
|
5,909,673
|
|
124,475
|
|
17,312
|
| |
|
|
|
|
|
|
Proposal 4.
|
|
|
|
|
|
|
Approval for the appointment of Kramer,
|
6,647,523
|
|
20,122
|
|
22,466
|
|
Weisman & Associates, Certified Public Accountants
|
|
|
|
|
|
|
& Consultants, as independent auditors for the year
|
|
|
|
|
|
|
ending December 31, 2010.
|
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: June 10, 2010 Ocean Bio-Chem, Inc.
By: /s/ Jeffrey S. Barocas
Name: Jeffrey S. Barocas
Title: Chief Financial Officer